Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26908739 | 0.97 | MEN1 (0.48) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL6202374 | 0.92 | KDM4C (0.46) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL30865753 | 0.88 | MEN1 (0.45) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL29963406 | 0.85 | MEN1 (0.65) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL4021594 | 0.84 | MEN1 (0.67) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL4118048 | 0.84 | MEN1 (0.64) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL31073145 | 0.83 | ICAM1 (0.42) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL18046352 | 0.83 | KDM4C (0.46) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL10680254 | 0.82 | MEN1 (0.51) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL4125006 | 0.82 | MEN1 (0.51) | MEN1KMT2AKDM4CL3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209011-A1 | HETEROAROMATIC PHOSPHONIUM SALTS FOR TREATING CANCER | FLORATEK PHARMA S A (CH) | 2024-06-27 | — | — | US | disclosed |
| US-20240209011-A1 | HETEROAROMATIC PHOSPHONIUM SALTS FOR TREATING CANCER | FLORATEK PHARMA S A (CH) | 2024-06-27 | — | — | US | disclosed |
| US-20240132461-A1 | FLAVONE DEAZA SPERMIDINE ANALOGUES AND THEIR USE TREATING CANCER | FLORATEK PHARMA S A (CH) | 2024-04-25 | — | — | US | disclosed |
| EP-4288421-A1 | FLAVONE DEAZA SPERMIDINE ANALOGUES AND THEIR USE TREATING CANCER | Floratek Pharma SA (CH) | 2023-12-13 | — | — | EP | disclosed |
| EP-4284517-A1 | HETEROAROMATIC PHOSPHONIUM SALTS FOR TREATING CANCER | Floratek Pharma SA (CH) | 2023-12-06 | — | — | EP | disclosed |
| US-20220411448-A1 | CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS | Floratek Pharma SA (CH) | 2022-12-29 | — | — | US | disclosed |
| US-20220411448-A1 | CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS | Floratek Pharma SA (CH) | 2022-12-29 | — | — | US | disclosed |
| WO-2022200540-A9 | HETERO BENZYL AMINES AND THEIR USE TREATING CENTRAL NERVOUS SYSTEM DISORDERS | Floratek Pharma SA (CH) | 2022-11-17 | — | — | WO | disclosed |
| WO-2022200540-A1 | HETERO BENZYL AMINES AND THEIR USE TREATING CENTRAL NERVOUS SYSTEM DISORDERS | Floratek Pharma SA (CH) | 2022-09-29 | — | — | WO | disclosed |
| WO-2022200542-A1 | FLAVONOID POLYAMINES AND THEIR USE TREATING CENTRAL NERVOUS SYSTEM DISORDERS | Floratek Pharma SA (CH) | 2022-09-29 | — | — | WO | disclosed |
| WO-2022167696-A1 | FLAVONE DEAZA SPERMIDINE ANALOGUES AND THEIR USE TREATING CANCER | Floratek Pharma SA (CH) | 2022-08-11 | — | — | WO | disclosed |
| WO-2022162029-A1 | HETEROAROMATIC PHOSPHONIUM SALTS FOR TREATING CANCER | FLORATEK PHARMA AG (CH) | 2022-08-04 | — | — | WO | disclosed |
| EP-4031538-A1 | CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS | Floratek Pharma AG (CH) | 2022-07-27 | — | — | EP | disclosed |
| WO-2021053205-A1 | CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS | FLORATEK PHARMA AG (CH) | 2021-03-25 | — | — | WO | disclosed |
| WO-2021053205-A1 | CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS | FLORATEK PHARMA AG (CH) | 2021-03-25 | — | — | WO | disclosed |
| US-20090124624-A1 | SUBSTITUTED 1-AMINOPHTHALAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF | SANOFI-AVENTIS (FR) | 2009-05-14 | — | — | US | disclosed |
| US-20090124624-A1 | SUBSTITUTED 1-AMINOPHTHALAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF | SANOFI-AVENTIS (FR) | 2009-05-14 | — | — | US | disclosed |
| US-20090124624-A1 | SUBSTITUTED 1-AMINOPHTHALAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF | SANOFI-AVENTIS (FR) | 2009-05-14 | — | — | US | disclosed |
| EP-1940823-A2 | SUBSTITUTED 1-AMINO-PHTHALZINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | Sanofi-Aventis (FR) | 2008-07-09 | — | — | EP | disclosed |
| WO-2007042660-A2 | SUBSTITUTED 1-AMINO-PHTHALZINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2007-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240209011-A1 | HETEROAROMATIC PHOSPHONIUM SALTS FOR TREATING CANCER | PIK3CA, TP53, CDK4 | MEN1 1580/4885KMT2A 1682/4885KDM4C 797/4885 |
| US-20220411448-A1 | CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS | BDNF, NTRK2, NGF | MEN1 3035/4885KMT2A 4496/4885KDM4C 4431/4885 |
| US-20240132461-A1 | FLAVONE DEAZA SPERMIDINE ANALOGUES AND THEIR USE TREATING CANCER | SRM, TP53, KDM5A | MEN1 1103/4885KMT2A 155/4885KDM4C 15/4885 |
| US-20090124624-A1 | SUBSTITUTED 1-AMINOPHTHALAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF | AGTR1, AGTR2, AHR | MEN1 2129/4885KMT2A 1253/4885KDM4C 1398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.